Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
About 180 million Covaxin doses have been administered in India and more than three million doses have been exported or donated
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
No paracetamol, painkillers recommended after Covaxin jab: Bharat Biotech
Medication is recommended only after consultation with a physician, the vaccine maker said
Covaxin demonstrates robust safety and immunogenicity in two-to-18 year old: Study
Bharat Biotech had conducted phase-II/III, open-label and multi-centre studies to evaluate the safety, reactogenicity and…
Covaxin receives approval for emergency use in 12-18 years old children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Bharat Biotech seeks nod for trial of intranasal vaccine as booster dose
An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to…
Covaxin’s shelf life extended to 12 months from date of manufacture
Covaxin Open Vial is stable at two-to-eight degrees Celsius for 28 days and not required to be discarded immediately in a day or…
Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 million doses,…
Both companies have achieved close to 90 per cent of present production capacity, Bharati Pravin Pawar, Minister of State for…
Covaxin and Covishield: The Sun and the Moon of Indian vaccine industry
Sudhir Phatak, Founder, Futurol Consultancy Services, explains how Bharat Biotech, like the sun, with its own R&D, has…
Bharat Biotech studying if Covaxin shot will work on Omicron
Covaxin was developed against the original Wuhan variant," according to a Bharat Biotech spokesperson
Bharat Biotech resumes Covaxin exports
The company also said exports to additional countries will commence from December, according to a statement it shared on Twitter